Evidence that descendants of three founders constitute about 25% of hemophilia B in the united states

Rhett P. Ketterling, Cynthia D K Bottema, John A. Phillips, Steve S. Sommer

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

In our sample of 160 consecutive Caucasian hemophiliacs, 14 (9%) had a G → A transition at bp 10,430 that substitutes serine for glycine 60 in the first EGF domain of the factor IX molecule. Each of these hemophiliacs had clinically mild disease. Haplotype data and familial pedigrees indicate that 12 of these hemophiliacs are likely to be related to a common ancestor. The 13th and 14th patients possess different haplotypes and thus represent independent origins of the mutation. In addition, we have screened these 160 hemophiliacs for the previously reported mutations resulting from founder effects at IIe397 → Thr and Thr296 → Met. Herein we report an additional nine hemophiliacs with the mutant Thr397 allele and five additional hemophiliacs with the mutant Met296 allele. Haplotype data for these 14 hemophiliacs support the original founder effect hypotheses for these mutations. In total, the above three mutations are found in 44 of the 160 seemingly unrelated Caucasian hemophiliacs (28%). The sample includes patierts from all regions of the United States and Ontario, Canada. Descendants of these three founders comprise approximately two-thirds of the missense mutations found in our sample of Caucasian hemophiliacs with clinically mild disease.

Original languageEnglish (US)
Pages (from-to)1093-1096
Number of pages4
JournalGenomics
Volume10
Issue number4
DOIs
StatePublished - 1991

Fingerprint

Hemophilia B
Haplotypes
Founder Effect
Mutation
Alleles
Factor IX
Ontario
Missense Mutation
Pedigree
Epidermal Growth Factor
Glycine
Serine
Canada

ASJC Scopus subject areas

  • Genetics

Cite this

Evidence that descendants of three founders constitute about 25% of hemophilia B in the united states. / Ketterling, Rhett P.; Bottema, Cynthia D K; Phillips, John A.; Sommer, Steve S.

In: Genomics, Vol. 10, No. 4, 1991, p. 1093-1096.

Research output: Contribution to journalArticle

Ketterling, Rhett P. ; Bottema, Cynthia D K ; Phillips, John A. ; Sommer, Steve S. / Evidence that descendants of three founders constitute about 25% of hemophilia B in the united states. In: Genomics. 1991 ; Vol. 10, No. 4. pp. 1093-1096.
@article{034c9745b5cd47e0a5e8f753279a8f70,
title = "Evidence that descendants of three founders constitute about 25{\%} of hemophilia B in the united states",
abstract = "In our sample of 160 consecutive Caucasian hemophiliacs, 14 (9{\%}) had a G → A transition at bp 10,430 that substitutes serine for glycine 60 in the first EGF domain of the factor IX molecule. Each of these hemophiliacs had clinically mild disease. Haplotype data and familial pedigrees indicate that 12 of these hemophiliacs are likely to be related to a common ancestor. The 13th and 14th patients possess different haplotypes and thus represent independent origins of the mutation. In addition, we have screened these 160 hemophiliacs for the previously reported mutations resulting from founder effects at IIe397 → Thr and Thr296 → Met. Herein we report an additional nine hemophiliacs with the mutant Thr397 allele and five additional hemophiliacs with the mutant Met296 allele. Haplotype data for these 14 hemophiliacs support the original founder effect hypotheses for these mutations. In total, the above three mutations are found in 44 of the 160 seemingly unrelated Caucasian hemophiliacs (28{\%}). The sample includes patierts from all regions of the United States and Ontario, Canada. Descendants of these three founders comprise approximately two-thirds of the missense mutations found in our sample of Caucasian hemophiliacs with clinically mild disease.",
author = "Ketterling, {Rhett P.} and Bottema, {Cynthia D K} and Phillips, {John A.} and Sommer, {Steve S.}",
year = "1991",
doi = "10.1016/0888-7543(91)90207-U",
language = "English (US)",
volume = "10",
pages = "1093--1096",
journal = "Genomics",
issn = "0888-7543",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Evidence that descendants of three founders constitute about 25% of hemophilia B in the united states

AU - Ketterling, Rhett P.

AU - Bottema, Cynthia D K

AU - Phillips, John A.

AU - Sommer, Steve S.

PY - 1991

Y1 - 1991

N2 - In our sample of 160 consecutive Caucasian hemophiliacs, 14 (9%) had a G → A transition at bp 10,430 that substitutes serine for glycine 60 in the first EGF domain of the factor IX molecule. Each of these hemophiliacs had clinically mild disease. Haplotype data and familial pedigrees indicate that 12 of these hemophiliacs are likely to be related to a common ancestor. The 13th and 14th patients possess different haplotypes and thus represent independent origins of the mutation. In addition, we have screened these 160 hemophiliacs for the previously reported mutations resulting from founder effects at IIe397 → Thr and Thr296 → Met. Herein we report an additional nine hemophiliacs with the mutant Thr397 allele and five additional hemophiliacs with the mutant Met296 allele. Haplotype data for these 14 hemophiliacs support the original founder effect hypotheses for these mutations. In total, the above three mutations are found in 44 of the 160 seemingly unrelated Caucasian hemophiliacs (28%). The sample includes patierts from all regions of the United States and Ontario, Canada. Descendants of these three founders comprise approximately two-thirds of the missense mutations found in our sample of Caucasian hemophiliacs with clinically mild disease.

AB - In our sample of 160 consecutive Caucasian hemophiliacs, 14 (9%) had a G → A transition at bp 10,430 that substitutes serine for glycine 60 in the first EGF domain of the factor IX molecule. Each of these hemophiliacs had clinically mild disease. Haplotype data and familial pedigrees indicate that 12 of these hemophiliacs are likely to be related to a common ancestor. The 13th and 14th patients possess different haplotypes and thus represent independent origins of the mutation. In addition, we have screened these 160 hemophiliacs for the previously reported mutations resulting from founder effects at IIe397 → Thr and Thr296 → Met. Herein we report an additional nine hemophiliacs with the mutant Thr397 allele and five additional hemophiliacs with the mutant Met296 allele. Haplotype data for these 14 hemophiliacs support the original founder effect hypotheses for these mutations. In total, the above three mutations are found in 44 of the 160 seemingly unrelated Caucasian hemophiliacs (28%). The sample includes patierts from all regions of the United States and Ontario, Canada. Descendants of these three founders comprise approximately two-thirds of the missense mutations found in our sample of Caucasian hemophiliacs with clinically mild disease.

UR - http://www.scopus.com/inward/record.url?scp=0026211963&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026211963&partnerID=8YFLogxK

U2 - 10.1016/0888-7543(91)90207-U

DO - 10.1016/0888-7543(91)90207-U

M3 - Article

C2 - 1916816

AN - SCOPUS:0026211963

VL - 10

SP - 1093

EP - 1096

JO - Genomics

JF - Genomics

SN - 0888-7543

IS - 4

ER -